

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 5.53743753 |
| 2 | microglial cell activation (GO:0001774) | 4.95473832 |
| 3 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.93719748 |
| 4 | macrophage activation involved in immune response (GO:0002281) | 4.92111650 |
| 5 | detection of other organism (GO:0098543) | 4.89054116 |
| 6 | detection of external biotic stimulus (GO:0098581) | 4.65022095 |
| 7 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.39822859 |
| 8 | neutrophil mediated immunity (GO:0002446) | 4.38962894 |
| 9 | detection of bacterium (GO:0016045) | 4.21029129 |
| 10 | macrophage activation (GO:0042116) | 4.14315414 |
| 11 | detection of biotic stimulus (GO:0009595) | 4.09169112 |
| 12 | response to interleukin-15 (GO:0070672) | 3.96638049 |
| 13 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.92566059 |
| 14 | B cell receptor signaling pathway (GO:0050853) | 3.91427303 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.89288828 |
| 16 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.87993239 |
| 17 | respiratory burst (GO:0045730) | 3.81075202 |
| 18 | myeloid leukocyte mediated immunity (GO:0002444) | 3.76793023 |
| 19 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.70144913 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.69965498 |
| 21 | negative regulation of T cell mediated immunity (GO:0002710) | 3.66627888 |
| 22 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.64257921 |
| 23 | nuclear pore complex assembly (GO:0051292) | 3.62291758 |
| 24 | myeloid cell activation involved in immune response (GO:0002275) | 3.59366869 |
| 25 | regulation of mast cell degranulation (GO:0043304) | 3.58707044 |
| 26 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.57729811 |
| 27 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.53636576 |
| 28 | cellular response to interleukin-15 (GO:0071350) | 3.48734342 |
| 29 | positive regulation of mast cell activation (GO:0033005) | 3.47829410 |
| 30 | regulation of mast cell activation (GO:0033003) | 3.45966783 |
| 31 | protein localization to kinetochore (GO:0034501) | 3.44299998 |
| 32 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.44224181 |
| 33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.44224181 |
| 34 | modulation by symbiont of host immune response (GO:0052553) | 3.44224181 |
| 35 | positive regulation by symbiont of host defense response (GO:0052509) | 3.44224181 |
| 36 | modulation by symbiont of host defense response (GO:0052031) | 3.44224181 |
| 37 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.44224181 |
| 38 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.43605916 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.42712975 |
| 40 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.42219382 |
| 41 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.41000665 |
| 42 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.34037650 |
| 43 | nuclear pore organization (GO:0006999) | 3.30409865 |
| 44 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.28814144 |
| 45 | regulation of B cell differentiation (GO:0045577) | 3.26738877 |
| 46 | activated T cell proliferation (GO:0050798) | 3.25526990 |
| 47 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.23843448 |
| 48 | regulation of leukocyte degranulation (GO:0043300) | 3.21292815 |
| 49 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.19314857 |
| 50 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.15390445 |
| 51 | dendritic cell migration (GO:0036336) | 3.15086407 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.12711120 |
| 53 | pore complex assembly (GO:0046931) | 3.11488075 |
| 54 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.06906131 |
| 55 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.02450609 |
| 56 | protein localization to chromosome, centromeric region (GO:0071459) | 2.98494615 |
| 57 | positive regulation of mast cell degranulation (GO:0043306) | 2.95908947 |
| 58 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.95908947 |
| 59 | positive thymic T cell selection (GO:0045059) | 2.93329805 |
| 60 | regulation of macrophage cytokine production (GO:0010935) | 2.90838456 |
| 61 | response to muramyl dipeptide (GO:0032495) | 2.89327522 |
| 62 | regulation of tolerance induction (GO:0002643) | 2.89271833 |
| 63 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.88478847 |
| 64 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.88478847 |
| 65 | NIK/NF-kappaB signaling (GO:0038061) | 2.84222643 |
| 66 | sister chromatid segregation (GO:0000819) | 2.83950884 |
| 67 | regulation of regulated secretory pathway (GO:1903305) | 2.82386634 |
| 68 | leukocyte degranulation (GO:0043299) | 2.81937688 |
| 69 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.80259637 |
| 70 | mitotic chromosome condensation (GO:0007076) | 2.80166890 |
| 71 | positive T cell selection (GO:0043368) | 2.80164979 |
| 72 | negative regulation of adaptive immune response (GO:0002820) | 2.79013689 |
| 73 | I-kappaB phosphorylation (GO:0007252) | 2.77180771 |
| 74 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.76953447 |
| 75 | kinetochore organization (GO:0051383) | 2.76883747 |
| 76 | negative regulation of B cell mediated immunity (GO:0002713) | 2.76498478 |
| 77 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.76498478 |
| 78 | germinal center formation (GO:0002467) | 2.76019791 |
| 79 | myeloid leukocyte activation (GO:0002274) | 2.75308242 |
| 80 | neutrophil chemotaxis (GO:0030593) | 2.74197335 |
| 81 | regulation of DNA endoreduplication (GO:0032875) | 2.72552904 |
| 82 | DNA unwinding involved in DNA replication (GO:0006268) | 2.72151975 |
| 83 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.70070505 |
| 84 | neutrophil activation involved in immune response (GO:0002283) | 2.68528868 |
| 85 | response to peptidoglycan (GO:0032494) | 2.67740749 |
| 86 | mitotic sister chromatid cohesion (GO:0007064) | 2.62883573 |
| 87 | positive regulation of interferon-alpha production (GO:0032727) | 2.60654073 |
| 88 | mitotic sister chromatid segregation (GO:0000070) | 2.55869329 |
| 89 | dosage compensation (GO:0007549) | 2.55305203 |
| 90 | modulation by symbiont of host cellular process (GO:0044068) | 2.54861256 |
| 91 | natural killer cell mediated immunity (GO:0002228) | 2.54713644 |
| 92 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.54713644 |
| 93 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.51587702 |
| 94 | regulation of interferon-alpha production (GO:0032647) | 2.50377369 |
| 95 | DNA topological change (GO:0006265) | 2.47807954 |
| 96 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.47608921 |
| 97 | mitotic nuclear envelope disassembly (GO:0007077) | 2.46760506 |
| 98 | immunoglobulin mediated immune response (GO:0016064) | 2.46634796 |
| 99 | meiotic chromosome segregation (GO:0045132) | 2.46318155 |
| 100 | regulation of mitotic spindle organization (GO:0060236) | 2.45944651 |
| 101 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.44707069 |
| 102 | response to host immune response (GO:0052572) | 2.44707069 |
| 103 | regulation of histone H3-K9 methylation (GO:0051570) | 2.43574303 |
| 104 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.43331700 |
| 105 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.43331700 |
| 106 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.43331700 |
| 107 | neutrophil activation (GO:0042119) | 2.43061776 |
| 108 | regulation of spindle organization (GO:0090224) | 2.42239722 |
| 109 | B cell homeostasis (GO:0001782) | 2.39312860 |
| 110 | hepatocyte apoptotic process (GO:0097284) | 2.38707015 |
| 111 | negative regulation of cell killing (GO:0031342) | 2.38565635 |
| 112 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.38565635 |
| 113 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.38298726 |
| 114 | mitotic metaphase plate congression (GO:0007080) | 2.38102386 |
| 115 | DNA geometric change (GO:0032392) | 2.35871686 |
| 116 | histone mRNA catabolic process (GO:0071044) | 2.35844775 |
| 117 | leukocyte aggregation (GO:0070486) | 2.34739980 |
| 118 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.34227041 |
| 119 | response to host (GO:0075136) | 2.34227041 |
| 120 | response to host defenses (GO:0052200) | 2.34227041 |
| 121 | DNA duplex unwinding (GO:0032508) | 2.33209569 |
| 122 | response to UV-C (GO:0010225) | 2.31474881 |
| 123 | histone H3-K36 demethylation (GO:0070544) | 2.31372099 |
| 124 | negative regulation of B cell proliferation (GO:0030889) | 2.31274627 |
| 125 | regulation of gamma-delta T cell activation (GO:0046643) | 2.31114246 |
| 126 | regulation of RNA export from nucleus (GO:0046831) | 2.30645511 |
| 127 | protein localization to chromosome (GO:0034502) | 2.29761181 |
| 128 | nuclear envelope disassembly (GO:0051081) | 2.28520855 |
| 129 | membrane disassembly (GO:0030397) | 2.28520855 |
| 130 | cellular extravasation (GO:0045123) | 2.27588998 |
| 131 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.27535172 |
| 132 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.27535172 |
| 133 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.26917647 |
| 134 | positive regulation of interferon-beta production (GO:0032728) | 2.26874832 |
| 135 | granulocyte activation (GO:0036230) | 2.26688059 |
| 136 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.26486283 |
| 137 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.25927573 |
| 138 | DNA replication checkpoint (GO:0000076) | 2.25764219 |
| 139 | pre-miRNA processing (GO:0031054) | 2.23830824 |
| 140 | negative regulation of histone methylation (GO:0031061) | 2.23050425 |
| 141 | regulation of integrin activation (GO:0033623) | 2.22987957 |
| 142 | positive regulation of chromosome segregation (GO:0051984) | 2.22366322 |
| 143 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.22242726 |
| 144 | establishment of chromosome localization (GO:0051303) | 2.21970008 |
| 145 | positive regulation of B cell differentiation (GO:0045579) | 2.21347191 |
| 146 | regulation of sister chromatid cohesion (GO:0007063) | 2.21245737 |
| 147 | pinocytosis (GO:0006907) | 2.19572829 |
| 148 | B cell mediated immunity (GO:0019724) | 2.19462222 |
| 149 | regulation of RIG-I signaling pathway (GO:0039535) | 2.18727631 |
| 150 | negative regulation of phagocytosis (GO:0050765) | 2.18437693 |
| 151 | T cell migration (GO:0072678) | 2.18367949 |
| 152 | DNA replication initiation (GO:0006270) | 2.17364139 |
| 153 | histone H3-K9 methylation (GO:0051567) | 2.17268049 |
| 154 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.16096906 |
| 155 | modulation by virus of host process (GO:0019054) | 2.15975787 |
| 156 | T cell apoptotic process (GO:0070231) | 2.15783106 |
| 157 | negative regulation of interleukin-12 production (GO:0032695) | 2.15408547 |
| 158 | negative thymic T cell selection (GO:0045060) | 2.14049043 |
| 159 | tolerance induction (GO:0002507) | 2.14015130 |
| 160 | metaphase plate congression (GO:0051310) | 2.13922570 |
| 161 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.12903176 |
| 162 | negative T cell selection (GO:0043383) | 2.12565993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.91447646 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 5.48863419 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.37328793 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.66305840 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.55615780 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.26607869 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.16135173 |
| 8 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.78663632 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.73111409 |
| 10 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.63764250 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.53964423 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.51603335 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.42002256 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.41776668 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29025843 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.23355094 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.19728460 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.18963608 |
| 19 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.16318727 |
| 20 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.10443364 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.09409214 |
| 22 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.05935815 |
| 23 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.03316172 |
| 24 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01109747 |
| 25 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.98227649 |
| 26 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.96137685 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.88229206 |
| 28 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77039102 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.75791251 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.75400698 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69210753 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68380153 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.66523188 |
| 34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.64392444 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.62412833 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59911837 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.58194919 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.56918360 |
| 39 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55648913 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54747181 |
| 41 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.52885095 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44125284 |
| 43 | GATA3_26560356_Chip-Seq_TH2_Human | 1.43907302 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43747556 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39235302 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38471833 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38193603 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36781186 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34951942 |
| 50 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34221222 |
| 51 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.33944165 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.31303921 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30666040 |
| 54 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.29098098 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28692246 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26776584 |
| 57 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.26528986 |
| 58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.26452923 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.25649237 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25097548 |
| 61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24192048 |
| 62 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.22853899 |
| 63 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21008867 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20584796 |
| 65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17960643 |
| 66 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.14218848 |
| 67 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.12471644 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12178586 |
| 69 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.11713469 |
| 70 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11159600 |
| 71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.08564654 |
| 72 | TP53_16413492_ChIP-PET_HCT116_Human | 1.07131286 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06862098 |
| 74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06680589 |
| 75 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06500197 |
| 76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05451324 |
| 77 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.04363486 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03936993 |
| 79 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.03592217 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01824109 |
| 81 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.01417834 |
| 82 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00373383 |
| 83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00125447 |
| 84 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99057405 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98057414 |
| 86 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96497568 |
| 87 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96414107 |
| 88 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95518173 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95078758 |
| 90 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.93999237 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93339895 |
| 92 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.93034017 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.93034017 |
| 94 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92125171 |
| 95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91925198 |
| 96 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91475314 |
| 97 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91358735 |
| 98 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88935254 |
| 99 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88615157 |
| 100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88457540 |
| 101 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.87072401 |
| 102 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.86338203 |
| 103 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84463170 |
| 104 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.84259869 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83734972 |
| 106 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.82644897 |
| 107 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.82256024 |
| 108 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.82170820 |
| 109 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.82027822 |
| 110 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80881144 |
| 111 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.80523168 |
| 112 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.80514521 |
| 113 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80313233 |
| 114 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80226796 |
| 115 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.79957704 |
| 116 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.79412803 |
| 117 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.79003838 |
| 118 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.77383707 |
| 119 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77230389 |
| 120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76794498 |
| 121 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.76628031 |
| 122 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75837662 |
| 123 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75721725 |
| 124 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.75451737 |
| 125 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.75437996 |
| 126 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75100034 |
| 127 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.74974159 |
| 128 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.74951926 |
| 129 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.74710449 |
| 130 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.74595808 |
| 131 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.74570537 |
| 132 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74397764 |
| 133 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.74397764 |
| 134 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.74105358 |
| 135 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73841482 |
| 136 | MAF_26560356_Chip-Seq_TH2_Human | 0.73411953 |
| 137 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.72377394 |
| 138 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.71788876 |
| 139 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.71198398 |
| 140 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.71087941 |
| 141 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70872574 |
| 142 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69599085 |
| 143 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69321993 |
| 144 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.67923062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.80411517 |
| 2 | MP0003828_pulmonary_edema | 2.56642968 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.54286099 |
| 4 | MP0010352_gastrointestinal_tract_polyps | 2.46061277 |
| 5 | MP0003303_peritoneal_inflammation | 2.44077043 |
| 6 | MP0008260_abnormal_autophagy | 2.43918258 |
| 7 | MP0003111_abnormal_nucleus_morphology | 2.40306309 |
| 8 | MP0010094_abnormal_chromosome_stability | 2.39659457 |
| 9 | MP0010307_abnormal_tumor_latency | 2.28329789 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.25044091 |
| 11 | MP0009278_abnormal_bone_marrow | 2.15047446 |
| 12 | MP0003693_abnormal_embryo_hatching | 2.09931815 |
| 13 | MP0003077_abnormal_cell_cycle | 2.09130804 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.05784191 |
| 15 | MP0008057_abnormal_DNA_replication | 2.03992741 |
| 16 | MP0005076_abnormal_cell_differentiation | 2.03397786 |
| 17 | MP0004808_abnormal_hematopoietic_stem | 2.02969887 |
| 18 | MP0003436_decreased_susceptibility_to | 2.00343110 |
| 19 | MP0001800_abnormal_humoral_immune | 1.94513130 |
| 20 | MP0002452_abnormal_antigen_presenting | 1.90891122 |
| 21 | MP0000685_abnormal_immune_system | 1.88701384 |
| 22 | MP0004883_abnormal_blood_vessel | 1.88216556 |
| 23 | MP0000490_abnormal_crypts_of | 1.87920117 |
| 24 | MP0009785_altered_susceptibility_to | 1.84424563 |
| 25 | MP0005451_abnormal_body_composition | 1.81788414 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.80287724 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.78980736 |
| 28 | MP0005671_abnormal_response_to | 1.76668882 |
| 29 | MP0005174_abnormal_tail_pigmentation | 1.76320072 |
| 30 | MP0008007_abnormal_cellular_replicative | 1.75857888 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.75513577 |
| 32 | MP0001790_abnormal_immune_system | 1.75171171 |
| 33 | MP0005387_immune_system_phenotype | 1.75171171 |
| 34 | MP0002398_abnormal_bone_marrow | 1.72196559 |
| 35 | MP0001819_abnormal_immune_cell | 1.71386117 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.70250745 |
| 37 | MP0002419_abnormal_innate_immunity | 1.69814721 |
| 38 | MP0002723_abnormal_immune_serum | 1.66117878 |
| 39 | MP0002132_abnormal_respiratory_system | 1.65162179 |
| 40 | MP0002006_tumorigenesis | 1.64435045 |
| 41 | MP0005025_abnormal_response_to | 1.60903627 |
| 42 | MP0000015_abnormal_ear_pigmentation | 1.60455672 |
| 43 | MP0003763_abnormal_thymus_physiology | 1.58956882 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.53053640 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.53053640 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.52359593 |
| 47 | MP0003448_altered_tumor_morphology | 1.52263372 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.51576810 |
| 49 | MP0002405_respiratory_system_inflammati | 1.50593341 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.47120181 |
| 51 | MP0004381_abnormal_hair_follicle | 1.47018828 |
| 52 | MP0000716_abnormal_immune_system | 1.46022351 |
| 53 | MP0003221_abnormal_cardiomyocyte_apopto | 1.45646459 |
| 54 | MP0008058_abnormal_DNA_repair | 1.43467919 |
| 55 | MP0003866_abnormal_defecation | 1.43174661 |
| 56 | MP0002722_abnormal_immune_system | 1.35381712 |
| 57 | * MP0000350_abnormal_cell_proliferation | 1.35063127 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.34853302 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.34099559 |
| 60 | MP0004957_abnormal_blastocyst_morpholog | 1.34084069 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.32720201 |
| 62 | MP0009764_decreased_sensitivity_to | 1.30561505 |
| 63 | MP0000858_altered_metastatic_potential | 1.30252186 |
| 64 | MP0002429_abnormal_blood_cell | 1.29303008 |
| 65 | MP0005164_abnormal_response_to | 1.29097574 |
| 66 | MP0001851_eye_inflammation | 1.27276264 |
| 67 | MP0005464_abnormal_platelet_physiology | 1.26260897 |
| 68 | MP0004947_skin_inflammation | 1.24341834 |
| 69 | MP0005257_abnormal_intraocular_pressure | 1.20849815 |
| 70 | MP0006082_CNS_inflammation | 1.18173075 |
| 71 | MP0006054_spinal_hemorrhage | 1.17277584 |
| 72 | MP0000371_diluted_coat_color | 1.15311257 |
| 73 | MP0001873_stomach_inflammation | 1.13710224 |
| 74 | MP0003690_abnormal_glial_cell | 1.13114343 |
| 75 | MP0003091_abnormal_cell_migration | 1.12574061 |
| 76 | MP0003566_abnormal_cell_adhesion | 1.09738028 |
| 77 | MP0003045_fibrosis | 1.09625624 |
| 78 | MP0000733_abnormal_muscle_development | 1.08016943 |
| 79 | MP0002009_preneoplasia | 1.06636179 |
| 80 | MP0002019_abnormal_tumor_incidence | 1.04713295 |
| 81 | MP0004484_altered_response_of | 1.03957225 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 1.03525168 |
| 83 | MP0002998_abnormal_bone_remodeling | 1.02556634 |
| 84 | MP0001533_abnormal_skeleton_physiology | 1.02522216 |
| 85 | MP0003121_genomic_imprinting | 1.01228754 |
| 86 | MP0003183_abnormal_peptide_metabolism | 1.00097660 |
| 87 | MP0002086_abnormal_extraembryonic_tissu | 1.00001995 |
| 88 | MP0008469_abnormal_protein_level | 0.99442317 |
| 89 | MP0003172_abnormal_lysosome_physiology | 0.98495533 |
| 90 | MP0005310_abnormal_salivary_gland | 0.98010988 |
| 91 | MP0002277_abnormal_respiratory_mucosa | 0.97668920 |
| 92 | MP0001672_abnormal_embryogenesis/_devel | 0.97042192 |
| 93 | MP0005380_embryogenesis_phenotype | 0.97042192 |
| 94 | MP0001845_abnormal_inflammatory_respons | 0.96473354 |
| 95 | MP0003705_abnormal_hypodermis_morpholog | 0.96293781 |
| 96 | MP0002095_abnormal_skin_pigmentation | 0.95762173 |
| 97 | * MP0001915_intracranial_hemorrhage | 0.95534823 |
| 98 | * MP0000313_abnormal_cell_death | 0.93566106 |
| 99 | MP0003724_increased_susceptibility_to | 0.92012469 |
| 100 | MP0005023_abnormal_wound_healing | 0.91800248 |
| 101 | MP0004510_myositis | 0.91614209 |
| 102 | MP0001730_embryonic_growth_arrest | 0.91277310 |
| 103 | MP0003941_abnormal_skin_development | 0.90707263 |
| 104 | MP0004197_abnormal_fetal_growth/weight/ | 0.90046965 |
| 105 | MP0008438_abnormal_cutaneous_collagen | 0.89653173 |
| 106 | MP0008932_abnormal_embryonic_tissue | 0.88102981 |
| 107 | MP0003984_embryonic_growth_retardation | 0.87862131 |
| 108 | MP0002877_abnormal_melanocyte_morpholog | 0.87743583 |
| 109 | MP0002088_abnormal_embryonic_growth/wei | 0.86745899 |
| 110 | MP0004130_abnormal_muscle_cell | 0.83652049 |
| 111 | MP0001697_abnormal_embryo_size | 0.83249155 |
| 112 | MP0005388_respiratory_system_phenotype | 0.81516023 |
| 113 | MP0002133_abnormal_respiratory_system | 0.81516023 |
| 114 | MP0003787_abnormal_imprinting | 0.79868806 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.79641881 |
| 116 | MP0005075_abnormal_melanosome_morpholog | 0.79521360 |
| 117 | MP0001958_emphysema | 0.78617181 |
| 118 | MP0002933_joint_inflammation | 0.77655086 |
| 119 | MP0000767_abnormal_smooth_muscle | 0.77484838 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.76885020 |
| 121 | MP0002084_abnormal_developmental_patter | 0.76374568 |
| 122 | MP0005621_abnormal_cell_physiology | 0.76123564 |
| 123 | MP0002928_abnormal_bile_duct | 0.75257743 |
| 124 | * MP0002085_abnormal_embryonic_tissue | 0.74976501 |
| 125 | MP0004264_abnormal_extraembryonic_tissu | 0.74723707 |
| 126 | MP0005409_darkened_coat_color | 0.73771592 |
| 127 | MP0001853_heart_inflammation | 0.73615422 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.69684139 |
| 129 | MP0009763_increased_sensitivity_to | 0.68912956 |
| 130 | MP0008004_abnormal_stomach_pH | 0.65731381 |
| 131 | MP0000249_abnormal_blood_vessel | 0.64035068 |
| 132 | MP0008877_abnormal_DNA_methylation | 0.60995915 |
| 133 | MP0003075_altered_response_to | 0.60624318 |
| 134 | MP0005390_skeleton_phenotype | 0.56919858 |
| 135 | MP0001663_abnormal_digestive_system | 0.55558047 |
| 136 | MP0005248_abnormal_Harderian_gland | 0.55466588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gastrointestinal infarctions (HP:0005244) | 4.41843191 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.24786727 |
| 3 | Chromsome breakage (HP:0040012) | 3.75681974 |
| 4 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.73250982 |
| 5 | Peritonitis (HP:0002586) | 3.64014976 |
| 6 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.61623511 |
| 7 | Gingival bleeding (HP:0000225) | 3.49413020 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.46198054 |
| 9 | Chest pain (HP:0100749) | 3.40267983 |
| 10 | Encephalitis (HP:0002383) | 3.10925933 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.10041070 |
| 12 | Prolonged bleeding time (HP:0003010) | 3.00292556 |
| 13 | Urticaria (HP:0001025) | 2.92901067 |
| 14 | Optic neuritis (HP:0100653) | 2.92748815 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 2.92748815 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 2.92711743 |
| 17 | Recurrent fungal infections (HP:0002841) | 2.89516013 |
| 18 | Myositis (HP:0100614) | 2.86313904 |
| 19 | Hypochromic microcytic anemia (HP:0004840) | 2.84634301 |
| 20 | Epistaxis (HP:0000421) | 2.80675957 |
| 21 | Orchitis (HP:0100796) | 2.73065386 |
| 22 | Recurrent viral infections (HP:0004429) | 2.70709744 |
| 23 | Ectopic kidney (HP:0000086) | 2.67757478 |
| 24 | Prostate neoplasm (HP:0100787) | 2.61342058 |
| 25 | Abnormality of the fingertips (HP:0001211) | 2.58809113 |
| 26 | Abnormality of T cells (HP:0002843) | 2.58375903 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 2.48221868 |
| 28 | Abnormality of chromosome stability (HP:0003220) | 2.42922830 |
| 29 | Hypochromic anemia (HP:0001931) | 2.40823005 |
| 30 | Abnormality of the peritoneum (HP:0002585) | 2.40563490 |
| 31 | Pulmonary embolism (HP:0002204) | 2.40366168 |
| 32 | Episodic fever (HP:0001954) | 2.35584534 |
| 33 | Inflammation of the large intestine (HP:0002037) | 2.34774371 |
| 34 | Amyloidosis (HP:0011034) | 2.33270876 |
| 35 | Anorexia (HP:0002039) | 2.27277026 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.27197495 |
| 37 | Obstructive lung disease (HP:0006536) | 2.27197495 |
| 38 | Volvulus (HP:0002580) | 2.24034182 |
| 39 | Difficulty running (HP:0009046) | 2.23639122 |
| 40 | Gingivitis (HP:0000230) | 2.23585696 |
| 41 | Periodontitis (HP:0000704) | 2.21974822 |
| 42 | Abnormality of the pleura (HP:0002103) | 2.20211734 |
| 43 | Papillary thyroid carcinoma (HP:0002895) | 2.19963114 |
| 44 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.19631069 |
| 45 | Short 4th metacarpal (HP:0010044) | 2.19631069 |
| 46 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.19182417 |
| 47 | Gastrointestinal inflammation (HP:0004386) | 2.17476069 |
| 48 | Autoimmune thrombocytopenia (HP:0001973) | 2.13447351 |
| 49 | Syringomyelia (HP:0003396) | 2.12286742 |
| 50 | Spinal cord lesions (HP:0100561) | 2.12286742 |
| 51 | Increased IgE level (HP:0003212) | 2.10931918 |
| 52 | Eosinophilia (HP:0001880) | 2.10733830 |
| 53 | Leukocytosis (HP:0001974) | 2.10111519 |
| 54 | Absent frontal sinuses (HP:0002688) | 2.09824649 |
| 55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.08791550 |
| 56 | Gangrene (HP:0100758) | 2.08774217 |
| 57 | Thyroiditis (HP:0100646) | 2.08422471 |
| 58 | Meckel diverticulum (HP:0002245) | 2.08228776 |
| 59 | Cheilitis (HP:0100825) | 2.07685394 |
| 60 | Abnormality of the preputium (HP:0100587) | 2.07468330 |
| 61 | Abnormality of the endocardium (HP:0004306) | 2.06980023 |
| 62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.06022887 |
| 63 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.06022887 |
| 64 | Subacute progressive viral hepatitis (HP:0006572) | 2.05454984 |
| 65 | Cellulitis (HP:0100658) | 2.05376462 |
| 66 | Hematochezia (HP:0002573) | 2.04918791 |
| 67 | Sepsis (HP:0100806) | 2.02426601 |
| 68 | Increased density of long bones (HP:0006392) | 2.02281485 |
| 69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.01331688 |
| 70 | Clubbing of toes (HP:0100760) | 2.00772164 |
| 71 | Myelodysplasia (HP:0002863) | 1.99856363 |
| 72 | Keratitis (HP:0000491) | 1.99838245 |
| 73 | Abnormality of the ileum (HP:0001549) | 1.99559260 |
| 74 | Prominent nose (HP:0000448) | 1.98774387 |
| 75 | Slow saccadic eye movements (HP:0000514) | 1.97059503 |
| 76 | Meningitis (HP:0001287) | 1.94523376 |
| 77 | Arterial thrombosis (HP:0004420) | 1.93968482 |
| 78 | IgM deficiency (HP:0002850) | 1.93862443 |
| 79 | Vasculitis (HP:0002633) | 1.92210282 |
| 80 | Microcytic anemia (HP:0001935) | 1.91204478 |
| 81 | Abnormality of T cell physiology (HP:0011840) | 1.90811538 |
| 82 | Duplicated collecting system (HP:0000081) | 1.90314061 |
| 83 | Glomerulopathy (HP:0100820) | 1.89960254 |
| 84 | Long eyelashes (HP:0000527) | 1.88838495 |
| 85 | Abnormality of DNA repair (HP:0003254) | 1.86857777 |
| 86 | Polycythemia (HP:0001901) | 1.86820716 |
| 87 | Colitis (HP:0002583) | 1.85828355 |
| 88 | Deviation of the thumb (HP:0009603) | 1.85090041 |
| 89 | Recurrent skin infections (HP:0001581) | 1.84630245 |
| 90 | Thrombophlebitis (HP:0004418) | 1.84585418 |
| 91 | Cutaneous melanoma (HP:0012056) | 1.84290690 |
| 92 | Lymphopenia (HP:0001888) | 1.83394465 |
| 93 | Abnormality of macrophages (HP:0004311) | 1.82859410 |
| 94 | Abnormality of the prostate (HP:0008775) | 1.81960617 |
| 95 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.81818696 |
| 96 | Pulmonary infiltrates (HP:0002113) | 1.81508384 |
| 97 | Reticulocytopenia (HP:0001896) | 1.81003399 |
| 98 | Pustule (HP:0200039) | 1.80341379 |
| 99 | Acute myeloid leukemia (HP:0004808) | 1.79564396 |
| 100 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.78393394 |
| 101 | Abnormality of T cell number (HP:0011839) | 1.77976968 |
| 102 | Uterine leiomyosarcoma (HP:0002891) | 1.77441458 |
| 103 | Leiomyosarcoma (HP:0100243) | 1.77441458 |
| 104 | Granulocytopenia (HP:0001913) | 1.77353080 |
| 105 | Metaphyseal cupping (HP:0003021) | 1.76180891 |
| 106 | Skin ulcer (HP:0200042) | 1.76138041 |
| 107 | Persistence of primary teeth (HP:0006335) | 1.74044947 |
| 108 | Abnormality of eosinophils (HP:0001879) | 1.73986401 |
| 109 | Proximal placement of thumb (HP:0009623) | 1.73930777 |
| 110 | Abnormality of the renal collecting system (HP:0004742) | 1.73900498 |
| 111 | Abnormality of B cell number (HP:0010975) | 1.73598423 |
| 112 | B lymphocytopenia (HP:0010976) | 1.73598423 |
| 113 | T lymphocytopenia (HP:0005403) | 1.73265372 |
| 114 | Increased mean platelet volume (HP:0011877) | 1.73208007 |
| 115 | Keratoconjunctivitis sicca (HP:0001097) | 1.72435570 |
| 116 | Vertigo (HP:0002321) | 1.72428913 |
| 117 | Osteomyelitis (HP:0002754) | 1.72239741 |
| 118 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.72076949 |
| 119 | Small intestinal stenosis (HP:0012848) | 1.71554802 |
| 120 | Duodenal stenosis (HP:0100867) | 1.71554802 |
| 121 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.70376961 |
| 122 | IgA deficiency (HP:0002720) | 1.70323508 |
| 123 | Abnormality of the carotid arteries (HP:0005344) | 1.69397151 |
| 124 | Abnormal platelet volume (HP:0011876) | 1.66387803 |
| 125 | Panhypogammaglobulinemia (HP:0003139) | 1.66241715 |
| 126 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.66171106 |
| 127 | Gastrointestinal carcinoma (HP:0002672) | 1.66171106 |
| 128 | Viral hepatitis (HP:0006562) | 1.65727737 |
| 129 | Abnormality of the nasal septum (HP:0000419) | 1.63818872 |
| 130 | Osteolytic defects of the hand bones (HP:0009699) | 1.63660631 |
| 131 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.63660631 |
| 132 | Stomach cancer (HP:0012126) | 1.62768133 |
| 133 | Paresthesia (HP:0003401) | 1.62656327 |
| 134 | Lymphoma (HP:0002665) | 1.62436508 |
| 135 | Abnormality of the pericardium (HP:0001697) | 1.62174280 |
| 136 | Amaurosis fugax (HP:0100576) | 1.61944355 |
| 137 | Leukopenia (HP:0001882) | 1.60690467 |
| 138 | Fatigue (HP:0012378) | 1.60101774 |
| 139 | Spontaneous hematomas (HP:0007420) | 1.59991054 |
| 140 | Wrist flexion contracture (HP:0001239) | 1.59969038 |
| 141 | Birth length less than 3rd percentile (HP:0003561) | 1.59858125 |
| 142 | Narrow palate (HP:0000189) | 1.59627015 |
| 143 | Severe combined immunodeficiency (HP:0004430) | 1.59148743 |
| 144 | Agnosia (HP:0010524) | 1.59040955 |
| 145 | Acute hepatic failure (HP:0006554) | 1.58743535 |
| 146 | Hemiplegia (HP:0002301) | 1.58431128 |
| 147 | Chronic diarrhea (HP:0002028) | 1.58277949 |
| 148 | Hemoptysis (HP:0002105) | 1.57890892 |
| 149 | Keratoconjunctivitis (HP:0001096) | 1.57710193 |
| 150 | Recurrent pneumonia (HP:0006532) | 1.57575573 |
| 151 | Cerebral aneurysm (HP:0004944) | 1.57419117 |
| 152 | Stomatitis (HP:0010280) | 1.57405998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.58097882 |
| 2 | MAP2K3 | 2.72710334 |
| 3 | CDC7 | 2.56832572 |
| 4 | MAP3K14 | 2.53025710 |
| 5 | FES | 2.50033465 |
| 6 | NEK2 | 2.45781407 |
| 7 | JAK3 | 2.10158607 |
| 8 | MAP3K10 | 2.09786865 |
| 9 | TYK2 | 2.06241048 |
| 10 | MAP4K1 | 1.99446555 |
| 11 | IRAK4 | 1.96919289 |
| 12 | ZAK | 1.84177585 |
| 13 | EPHB1 | 1.82897358 |
| 14 | PIK3CG | 1.79095464 |
| 15 | STK3 | 1.78881846 |
| 16 | STK10 | 1.74862660 |
| 17 | TXK | 1.72350354 |
| 18 | KSR2 | 1.72284548 |
| 19 | EEF2K | 1.70048767 |
| 20 | BRD4 | 1.69166133 |
| 21 | PIM1 | 1.63876009 |
| 22 | MAP3K2 | 1.61367876 |
| 23 | BMPR2 | 1.59379561 |
| 24 | MKNK1 | 1.58866459 |
| 25 | STK4 | 1.58024240 |
| 26 | BLK | 1.57758625 |
| 27 | MKNK2 | 1.56737154 |
| 28 | MAP3K6 | 1.51287559 |
| 29 | PRPF4B | 1.48325357 |
| 30 | JAK2 | 1.47087932 |
| 31 | ATR | 1.46459630 |
| 32 | CHUK | 1.46014659 |
| 33 | TTK | 1.45648422 |
| 34 | KIT | 1.44654242 |
| 35 | IKBKB | 1.43471132 |
| 36 | JAK1 | 1.38683409 |
| 37 | CDK6 | 1.34588661 |
| 38 | LATS1 | 1.33388762 |
| 39 | IKBKE | 1.31851332 |
| 40 | TTN | 1.31181364 |
| 41 | TBK1 | 1.29432535 |
| 42 | SRPK1 | 1.27529011 |
| 43 | RPS6KA4 | 1.25722681 |
| 44 | IRAK3 | 1.23850866 |
| 45 | IRAK1 | 1.22857631 |
| 46 | NUAK1 | 1.22764585 |
| 47 | KSR1 | 1.22605706 |
| 48 | FGFR3 | 1.21412820 |
| 49 | EIF2AK2 | 1.18536357 |
| 50 | TNK2 | 1.17064767 |
| 51 | SIK2 | 1.16686562 |
| 52 | ERN1 | 1.16439720 |
| 53 | WNK1 | 1.14659427 |
| 54 | CDK4 | 1.13949578 |
| 55 | MAP3K13 | 1.12172423 |
| 56 | BTK | 1.12004385 |
| 57 | WEE1 | 1.11967321 |
| 58 | TEC | 1.11262353 |
| 59 | AURKB | 1.09766521 |
| 60 | PTK6 | 1.07217295 |
| 61 | TLK1 | 1.06605396 |
| 62 | MARK2 | 1.06564604 |
| 63 | HCK | 1.04177047 |
| 64 | CSF1R | 1.03976844 |
| 65 | SIK3 | 1.00633684 |
| 66 | GRK6 | 1.00076943 |
| 67 | CHEK2 | 0.99585770 |
| 68 | PKN2 | 0.99440150 |
| 69 | PLK1 | 0.98717593 |
| 70 | SGK2 | 0.97818936 |
| 71 | MAP3K3 | 0.96313712 |
| 72 | MAP2K4 | 0.95472126 |
| 73 | MAP3K1 | 0.94566361 |
| 74 | PLK4 | 0.93913631 |
| 75 | CLK1 | 0.92216282 |
| 76 | CSK | 0.92115426 |
| 77 | PTK2B | 0.91856606 |
| 78 | RAF1 | 0.90575461 |
| 79 | CHEK1 | 0.90572765 |
| 80 | MAP3K8 | 0.90521543 |
| 81 | CAMKK2 | 0.90398619 |
| 82 | RPS6KB2 | 0.90256488 |
| 83 | SGK3 | 0.90034705 |
| 84 | SCYL2 | 0.89699744 |
| 85 | CDK7 | 0.89467891 |
| 86 | LCK | 0.88302004 |
| 87 | TAOK1 | 0.88116323 |
| 88 | TAOK3 | 0.88110385 |
| 89 | DYRK3 | 0.87702739 |
| 90 | CDK9 | 0.86471476 |
| 91 | CAMK1D | 0.85824195 |
| 92 | RET | 0.83452650 |
| 93 | ATM | 0.82830394 |
| 94 | PLK3 | 0.81079330 |
| 95 | YES1 | 0.80503847 |
| 96 | ITK | 0.80486789 |
| 97 | TRPM7 | 0.80467123 |
| 98 | ACVR1B | 0.79959281 |
| 99 | MAP3K7 | 0.79293845 |
| 100 | MELK | 0.78353381 |
| 101 | BMX | 0.78273021 |
| 102 | RIPK1 | 0.77458072 |
| 103 | EPHA3 | 0.76183243 |
| 104 | DYRK1B | 0.75274280 |
| 105 | BUB1 | 0.75067086 |
| 106 | STK11 | 0.74749965 |
| 107 | NLK | 0.74048345 |
| 108 | ALK | 0.73861949 |
| 109 | PDK1 | 0.73184063 |
| 110 | FGFR4 | 0.71735381 |
| 111 | EPHA2 | 0.71689946 |
| 112 | MARK3 | 0.71006322 |
| 113 | ZAP70 | 0.69941026 |
| 114 | MATK | 0.69493174 |
| 115 | SYK | 0.68228488 |
| 116 | PAK4 | 0.67460526 |
| 117 | LYN | 0.64448449 |
| 118 | RIPK4 | 0.63711607 |
| 119 | LRRK2 | 0.63045094 |
| 120 | TGFBR1 | 0.61343729 |
| 121 | MAP3K5 | 0.60862289 |
| 122 | STK38 | 0.60720843 |
| 123 | IRAK2 | 0.60349157 |
| 124 | FGR | 0.59315094 |
| 125 | MTOR | 0.58202099 |
| 126 | CDK2 | 0.57644072 |
| 127 | NEK9 | 0.57167232 |
| 128 | CDK19 | 0.57067531 |
| 129 | CAMK1G | 0.56451954 |
| 130 | ERBB3 | 0.55151126 |
| 131 | FYN | 0.55096194 |
| 132 | FRK | 0.54797032 |
| 133 | STK24 | 0.52389210 |
| 134 | PIM2 | 0.49012603 |
| 135 | PDGFRB | 0.47389260 |
| 136 | AKT1 | 0.47278769 |
| 137 | PASK | 0.46866982 |
| 138 | PDPK1 | 0.46605079 |
| 139 | TGFBR2 | 0.45654726 |
| 140 | RPS6KA5 | 0.44139191 |
| 141 | CAMK4 | 0.42493930 |
| 142 | FLT3 | 0.41724255 |
| 143 | MAPK7 | 0.41707016 |
| 144 | TAOK2 | 0.41096498 |
| 145 | ABL1 | 0.41049544 |
| 146 | PRKCQ | 0.39726814 |
| 147 | EGFR | 0.39262307 |
| 148 | DYRK1A | 0.35050963 |
| 149 | SGK1 | 0.32938681 |
| 150 | SGK223 | 0.32689902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.06516876 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 1.92755714 |
| 3 | Measles_Homo sapiens_hsa05162 | 1.80605608 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 1.78967563 |
| 5 | Cell cycle_Homo sapiens_hsa04110 | 1.71142596 |
| 6 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.63889132 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.62977419 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61946921 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.55535561 |
| 10 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.55191845 |
| 11 | * p53 signaling pathway_Homo sapiens_hsa04115 | 1.54654651 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.54560696 |
| 13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.50230703 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.48350824 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48009394 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.44024835 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42993250 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38466452 |
| 19 | Mismatch repair_Homo sapiens_hsa03430 | 1.38312586 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37667909 |
| 21 | * Small cell lung cancer_Homo sapiens_hsa05222 | 1.36926133 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.36563646 |
| 23 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.35475419 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.33663233 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33267803 |
| 26 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.32739672 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.32599407 |
| 28 | Homologous recombination_Homo sapiens_hsa03440 | 1.32329088 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31546433 |
| 30 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.31266457 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.31116581 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31052741 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30139584 |
| 34 | * Apoptosis_Homo sapiens_hsa04210 | 1.28318394 |
| 35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.27355691 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.27231965 |
| 37 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.25298376 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24350270 |
| 39 | Spliceosome_Homo sapiens_hsa03040 | 1.24255366 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.22442766 |
| 41 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.22164748 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.21530097 |
| 43 | * Hepatitis B_Homo sapiens_hsa05161 | 1.19449751 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.19261457 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16883222 |
| 46 | RNA transport_Homo sapiens_hsa03013 | 1.15493605 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.15038730 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.12861794 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11501670 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08695508 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 1.08484748 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08091874 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07008392 |
| 54 | * Tuberculosis_Homo sapiens_hsa05152 | 1.05144656 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04909590 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04432720 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03132193 |
| 58 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.02757909 |
| 59 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.02150602 |
| 60 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.01982057 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01551833 |
| 62 | * Legionellosis_Homo sapiens_hsa05134 | 0.99527222 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99424539 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99050062 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97494939 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97278105 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96286435 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.94300379 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94162795 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.93742942 |
| 71 | Colorectal cancer_Homo sapiens_hsa05210 | 0.91436793 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.91070745 |
| 73 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.90326987 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.90205385 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89901038 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89619038 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88409619 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.88104263 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88073502 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87710529 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87427383 |
| 82 | Adherens junction_Homo sapiens_hsa04520 | 0.86109202 |
| 83 | Glioma_Homo sapiens_hsa05214 | 0.84660803 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84450167 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82065329 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81169511 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.80853010 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.76659860 |
| 89 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.75774898 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75196207 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75003358 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74954946 |
| 93 | RNA degradation_Homo sapiens_hsa03018 | 0.74209009 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.72603816 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.68988662 |
| 96 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68390130 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67385668 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67344053 |
| 99 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.66358203 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66297153 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.66108125 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65231297 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.65219068 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64102275 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63725418 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63676404 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62041537 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60502201 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58983191 |
| 110 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58187987 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.57695792 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.57665061 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57640523 |
| 114 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.57518195 |
| 115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57512103 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57275028 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55216271 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55064221 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54442960 |
| 120 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.54300720 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52767851 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.52603537 |
| 123 | Basal transcription factors_Homo sapiens_hsa03022 | 0.51915483 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51859827 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51015663 |
| 126 | Long-term depression_Homo sapiens_hsa04730 | 0.49640455 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49249466 |
| 128 | Melanoma_Homo sapiens_hsa05218 | 0.48969772 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48425199 |
| 130 | Long-term potentiation_Homo sapiens_hsa04720 | 0.48216368 |
| 131 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47326123 |
| 132 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45659634 |

